Company intelligence / Profile preview

China Orient Asset Management

Beijing, People's Republic of China

Ownership: Private
Employees: ~50000
Development stage: Other

Overview

China Orient is a state-owned financial enterprise, not primarily a life science/biotech/pharma company. However, it has established healthcare-related investment operations through subsidiaries and funds focused on medical services consolidation and healthcare sector investments.

Industry: Investors

Partnerships

Aier Eye Hospital Group (ophthalmic healthcare M&A fund partnership)

Beyond the preview

Go deeper on China Orient Asset Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on China Orient Asset Management.

Explore the full profile